annual ROE:
-95.21%+32.43%(+25.41%)Summary
- As of today (September 16, 2025), OCUL annual return on equity is -95.21%, with the most recent change of +32.43% (+25.41%) on December 31, 2024.
- During the last 3 years, OCUL annual ROE has fallen by -87.22% (-1091.61%).
- OCUL annual ROE is now -1091.61% below its all-time high of -7.99%, reached on December 31, 2021.
Performance
OCUL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-67.03%-10.98%(-19.59%)Summary
- As of today (September 16, 2025), OCUL quarterly return on equity is -67.03%, with the most recent change of -10.98% (-19.59%) on June 30, 2025.
- Over the past year, OCUL quarterly ROE has increased by +10.90% (+13.99%).
- OCUL quarterly ROE is now -102.28% below its all-time high of 2939.06%, reached on September 30, 2020.
Performance
OCUL quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
OCUL ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.4% | +14.0% |
| 3 y3 years | -1091.6% | -65.5% |
| 5 y5 years | +82.2% | +98.6% |
OCUL ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1091.6% | +25.4% | -65.5% | +79.6% |
| 5 y | 5-year | -1091.6% | +82.2% | -102.3% | +98.6% |
| alltime | all time | -1091.6% | +82.2% | -102.3% | +98.6% |
OCUL ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -67.03%(+19.6%) |
| Mar 2025 | - | -56.05%(-10.5%) |
| Dec 2024 | -95.21%(-25.4%) | -62.66%(-11.1%) |
| Sep 2024 | - | -70.49%(-9.5%) |
| Jun 2024 | - | -77.93%(-29.7%) |
| Mar 2024 | - | -110.88%(-59.6%) |
| Dec 2023 | -127.64%(+10.8%) | -274.31%(-16.3%) |
| Sep 2023 | - | -327.88%(+15.8%) |
| Jun 2023 | - | -283.16%(+51.1%) |
| Mar 2023 | - | -187.44%(+66.3%) |
| Dec 2022 | -115.16%(+1341.3%) | -112.69%(+39.4%) |
| Sep 2022 | - | -80.82%(+99.5%) |
| Jun 2022 | - | -40.51%(+52.8%) |
| Mar 2022 | - | -26.52%(+236.1%) |
| Dec 2021 | -7.99%(-98.1%) | -7.89%(-94.2%) |
| Sep 2021 | - | -136.73%(-36.0%) |
| Jun 2021 | - | -213.55%(-51.1%) |
| Mar 2021 | - | -436.50%(-64.6%) |
| Dec 2020 | -429.55%(-19.8%) | -1234.74%(-142.0%) |
| Sep 2020 | - | 2939.06%(-160.6%) |
| Jun 2020 | - | -4846.19%(+230.2%) |
| Mar 2020 | - | -1467.75%(+163.2%) |
| Dec 2019 | -535.72% | -557.58%(+81.6%) |
| Sep 2019 | - | -307.09%(+33.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | -229.73%(+46.5%) |
| Mar 2019 | - | -156.81%(+5.9%) |
| Dec 2018 | -193.41%(+19.2%) | -148.13%(+7.7%) |
| Sep 2018 | - | -137.48%(+0.2%) |
| Jun 2018 | - | -137.16%(+0.2%) |
| Mar 2018 | - | -136.95%(-2.3%) |
| Dec 2017 | -162.21%(+156.9%) | -140.23%(+16.5%) |
| Sep 2017 | - | -120.36%(+25.0%) |
| Jun 2017 | - | -96.29%(+26.9%) |
| Mar 2017 | - | -75.85%(+20.3%) |
| Dec 2016 | -63.14%(+17.8%) | -63.05%(+19.0%) |
| Sep 2016 | - | -52.97%(+6.8%) |
| Jun 2016 | - | -49.59%(-0.9%) |
| Mar 2016 | - | -50.04%(+2.8%) |
| Dec 2015 | -53.61%(-31.2%) | -48.68%(+0.9%) |
| Sep 2015 | - | -48.23%(-14.7%) |
| Jun 2015 | - | -56.53%(-25.7%) |
| Mar 2015 | - | -76.08%(-7.1%) |
| Dec 2014 | -77.88%(-0.5%) | -81.90%(-6.8%) |
| Sep 2014 | - | -87.87%(-195.7%) |
| Jun 2014 | - | 91.86%(+121.3%) |
| Mar 2014 | - | 41.51%(+291.6%) |
| Dec 2013 | -78.30%(+6.5%) | 10.60% |
| Dec 2012 | -73.54% | - |
FAQ
- What is Ocular Therapeutix, Inc. annual return on equity?
- What is the all time high annual ROE for Ocular Therapeutix, Inc.?
- What is Ocular Therapeutix, Inc. annual ROE year-on-year change?
- What is Ocular Therapeutix, Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Ocular Therapeutix, Inc.?
- What is Ocular Therapeutix, Inc. quarterly ROE year-on-year change?
What is Ocular Therapeutix, Inc. annual return on equity?
The current annual ROE of OCUL is -95.21%
What is the all time high annual ROE for Ocular Therapeutix, Inc.?
Ocular Therapeutix, Inc. all-time high annual return on equity is -7.99%
What is Ocular Therapeutix, Inc. annual ROE year-on-year change?
Over the past year, OCUL annual return on equity has changed by +32.43% (+25.41%)
What is Ocular Therapeutix, Inc. quarterly return on equity?
The current quarterly ROE of OCUL is -67.03%
What is the all time high quarterly ROE for Ocular Therapeutix, Inc.?
Ocular Therapeutix, Inc. all-time high quarterly return on equity is 2939.06%
What is Ocular Therapeutix, Inc. quarterly ROE year-on-year change?
Over the past year, OCUL quarterly return on equity has changed by +10.90% (+13.99%)